Impact of transplant centre volume on pharmacy services
| Characteristics | Number of transplants performed per year (n=number of transplant centres)† | P value | Time per patient per session (min) | ||||
| 0–100 (n=35) | 101–200 (n=25) | 201–300 (n=9) | >300 (n=9) | ||||
| Average numbers of pharmacist | 1.3 | 1.0 | 1.7 | 1.1 | 0.255 | – | |
| Evaluation phase | Medication adherence assessment | 62.9% (22/35) | 44.0% (11/25) | 55.6% (5/9) | 44.4% (4/9) | 0.484 | – |
| Medication reconciliation | 88.6% (31/35) | 64.0% (16/25) | 66.7% (6/9) | 44.4% (4/9) | 0.026* | 21.0±13.1 | |
| Transplant phase | Pharmaceutical ward round | 71.4% (25/35) | 64.0% (16/25) | 100.0% (9/9) | 77.8% (7/9) | 0.211 | 13.3±9.3 |
| Medical order review | 71.4% (25/35) | 60.0% (15/25) | 100.0% (9/9) | 77.8% (7/9) | 0.144 | 15.8±12.3 | |
| Medication education | 68.6% (24/35) | 60.0% (15/25) | 88.9% (8/9) | 66.7% (6/9) | 0.466 | 10.2±6.3 | |
| Post-transplant phase | Pharmacist-managed clinic | 11.4% (4/35) | 16.0% (4/25) | 22.2% (2/9) | 44.4% (4/9) | 0.140 | – |
*P value of<0.05 was considered statistically significant.
†Percentage (%)=(Number of centres providing the service in the group/Total number of centres in the group)×100%.